Global health aid sinks to 15-year low in ‘era of austerity'
PARIS : Sweeping foreign aid cuts led by the US will cause international health funding to plummet to the lowest level in 15 years, a study said Wednesday, warning the world has entered a new 'era of global health austerity.'
Money that provides healthcare to some of the poorest and most in-need people across the world has been dramatically slashed this year, led by the administration of US President Donald Trump.
The new study published in the prestigious Lancet journal also pointed to recent steep aid cuts announced by the UK, France and Germany.
After reaching an all-time high of US$80 billion in 2021 during the Covid-19 pandemic, the total amount of global health aid will sink to US$39 billion this year, the US-led team of researchers estimated.
That would be the lowest level since 2009.
Such a dramatic change will result in the world entering a new 'era of global health austerity', the authors of the study warned.
Sub-Saharan African countries such as Somalia, the war-torn Democratic of Congo and Malawi will be hit worst because most of their health funding currently comes from international aid, according to the study.
The funding cuts will have a major impact on the treatment and prevention of a range of diseases, including HIV/AIDS, malaria and tuberculosis, it added
The US slashed its global health funding by at least 67% in 2025 compared to last year, according to the research. The UK cut its funding by nearly 40%, following by France with 33% and Germany with 12%.
The researchers at the US-based Institute for Health Metrics and Evaluation called for the world to urgently ramp up health aid. They also warned that nations would likely need find other sources of funding.
The study was released as AIDS experts meet in Rwanda's capital Kigali for an international conference on HIV science.
The US foreign aid cuts alone are estimated to result in the preventable deaths of more than 14 million people by 2030, according to a different Lancet study published earlier this month.
For comparison, around 10 million soldiers were killed during World War I.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Sun
6 hours ago
- The Sun
Biotech Breakthroughs in Anti-Aging: Decoding the Hallmarks of Aging and the Longevity Code
--> Clinical Evidence Confirms Anti-Aging Efficacy of Plant-Based Stem Cell Exosomes – A Truly Effective Age-Defying Breakthrough HONG KONG SAR - Media OutReach Newswire - 16 July 2025 - From the popularity of anti-aging supplements and aesthetic treatments to Silicon Valley billionaires' pursuit of immortality, the global wave of anti-aging is gaining momentum, and Hong Kong is no exception. Questions like 'How to stay young?', 'Is NMN really effective?' and 'At what age should you start anti-aging care?' have become part of everyday conversation. While many are eager to delay the signs of aging, few truly understand the science behind it. From Hallmarks of Aging to Scientific Action: Effective Solutions Revealed To address this knowledge gap, Dr. Fred Zülli, Founder and Business Development Director of Swiss-based biotech company Mibelle Biochemistry, was specially invited to Hong Kong to co-host a seminar with the Hong Kong Society of Cosmetic Chemists. The seminar provided an in-depth look at the latest advancements in Swiss anti-aging research, starting with the 12 'Hallmarks of Aging' theory published in the journal Cell. Dr. Zülli explained how Swiss biotechnology is strategically targeting these biological mechanisms of aging and translating scientific breakthroughs into practical applications in skincare and aesthetic medicine, making age-defying solutions a scientific reality rather than a distant ideal. During the seminar, Dr. Zülli also revealed several truly effective, science-backed methods to combat aging. Next-Gen Skincare Science: Goji Stem Cell Extract with Dual Action Power for Repair Exosomes have rapidly emerged as one of the most promising technologies in the skincare industry. According to market data, the global exosome market was valued at over US$140 million in 2023 and is projected to expand at 28% CAGR by 2030. In the U.S., Google searches for 'exosomes' surged 17% in one year, evidence of rising consumer interest. Dr. Fred Zülli explains that exosomes are tiny vesicles that are released by cells into the extracellular space, rich in proteins, lipids, and nucleic acids. They can be derived from human, animals or plants cells, including plant stem cells, and reconstructed using liposome technology. These 'cellular messengers' play key roles in intercellular communication, immune modulation, and drug delivery. When used in skincare or microneedling treatments, they accelerate wound healing, enhance skin regeneration, and deliver deeper, faster, and safer results. Exosomes offer dual benefits: they strengthen the skin barrier while activating deeper cellular repair, improving overall skin quality, reducing fine lines, and restoring firmness for true inside-out anti-aging effects. Clinically Proven Plant Stem Cells Go Beyond Surface-Level Skincare Swiss researchers at Mibelle have developed the PhytoCellTec™ Exosomes technology, using natural Goji Stem Cell Extract to stimulate exosome production. This powerful natural ingredient demonstrates 'dual action', promoting keratinocyte differentiation and the expression of epidermal growth and antioxidant-related genes to reinforce the skin's outer barrier. Meanwhile, it reactivates mesenchymal stem cells (MSCs), boosting collagen synthesis and cellular vitality to enhance skin elasticity and density. Clinical studies show that a cream containing just 0.4% of Goji Stem Cell Extract significantly reduces fine lines and wrinkles after 56 days. Results can be seen in just 28 days with improved skin density and facial contour, and even firmness and lifting effects when applied to the breast area, showcasing its applications well beyond facial skincare. Exosomes in Daily Skincare and Medical Aesthetics With proven regenerative and wound-healing properties, exosomes are emerging as a viable alternative to stem cell therapies. As non-living biological elements, they are more stable and easier to handle. Exosome-based serums are particularly effective when used with microneedling, enabling deep skin repair and faster healing. Plant-derived exosomes have been shown to be bioavailable to mammalian cells and exhibit anti-inflammatory, antioxidant, anti-tumour, and skin-repairing benefits. Recent studies confirm their ability to combat skin aging, reinforcing their growing role in both cosmetic dermatology and everyday skincare. As this technology evolves, it promises a new era of personalized, science-backed beauty. Dual Stem Cell Formula: 'Swiss StemGlow Jelly' Nourishes Youthful Skin from Within; The brand 'LAB 91' Unveils Advanced Microneedle Skincare Powered by Deep Cellular Repair The Swiss StemGlow Jelly is an edible functional jelly formulated with dual stem cell active ingredients, Swiss apple stem cells and grape stem cells. These ingredients are renowned for enhancing cellular vitality, delivering antioxidant protection, and shielding the skin from UV damage. Meanwhile, LAB 91, a Swiss-made brand, specializes in microneedle skincare solutions. Its signature innovation, the Dual Plant Stem Cell Exosome Complex, combines rare Swiss apple stem cells with goji stem cells to deeply penetrate the skin and trigger cellular repair. Proven results include improved skin elasticity, lifted facial contours, and visibly diminished wrinkles. The brand offers a range of ampoule serums tailored to various skin concerns, including anti-aging, brightening and intensive repair. Together, the edible jelly and topical microneedle treatments deliver synergistic, cell-level rejuvenation from the inside out.
Barnama
6 hours ago
- Barnama
Japan Discards State-Acquired COVID-19 Drugs Worth US$1.6 Billion
TOKYO, July 16 (Bernama-Kyodo) -- The Japanese government discarded COVID-19 oral medicines believed to be worth around 240 billion yen (US$1.6 billion) in the fiscal year through March as they had passed their expiry dates, Kyodo News Agency reported, citing health ministry officials on Wednesday. While the exact purchase price remains unclear, the value was calculated in accordance with current prices. The amount is enough to treat some 2.5 million people. The government acquired the oral drugs at the height of the coronavirus pandemic and provided them free of charge to hospitals and clinics nationwide.
The Sun
8 hours ago
- The Sun
Gaza aid point stampede leaves 20 dead amid chaos
GAZA CITY: The Gaza Humanitarian Foundation reported 20 fatalities at an aid distribution point in Khan Yunis, southern Gaza, on Wednesday, attributing the deaths to armed agitators within the crowd. The US- and Israel-backed organisation stated that 19 victims died in a stampede while one was stabbed during a chaotic surge. A medical source at Nasser Hospital provided a conflicting toll, confirming nine fatalities, including children, after Israeli forces allegedly opened fire. The victims were reportedly heading to an aid centre in northwest Rafah when the main gate was closed, leading to the shooting. The GHF accused Hamas-affiliated individuals of inciting unrest, citing the presence of firearms in the crowd. An American aid worker was threatened during the incident, marking a troubling escalation. The UN has recorded 875 starvation-related deaths in Gaza since late May, with 674 occurring near GHF sites. The Israeli military has not commented, while the GHF denies direct responsibility for shootings near its aid points. The incident highlights worsening humanitarian conditions as Gaza faces severe food shortages. – AFP
